PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL)
Clinical trials for PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL) explained in plain language.
Never miss a new study
Get alerted when new PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL) trials appear
Sign up with your email to follow new studies for PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to outsmart leukemia with less poison
Disease control Not yet recruitingThis phase 2 trial is testing a new way to treat adults newly diagnosed with a specific type of acute lymphoblastic leukemia (Ph-negative B-ALL). Instead of standard high-dose chemotherapy, patients receive a mix of low-dose chemo plus several targeted drugs (inotuzumab ozogamici…
Matched conditions: PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo therapy aims to keep leukemia away after transplant
Disease control Not yet recruitingThis phase 2 trial tests whether adding asciminib to standard tyrosine kinase inhibitors can prevent relapse in patients with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia or blastic phase chronic myeloid leukemia after a stem cell transplant. 45 participan…
Matched conditions: PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL)
Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC